Skip to main content
Copyright Blog

Adhering to Licensing Terms for a Medication Adherence Scale

MMAS Research takes on another British institution of higher education

In late July of 2022, MMAS Research ("MMAS") filed a Complaint against the University of Wolverhampton ("Wolverhampton"), Morisky Medication Adherence Research LLC ("MMAR"), Donald Morisky, Philip Morisky, and several unknown or unidentified individuals. This is yet another in a series of suits that MMAS has brought against various institutions for misuse of intellectual property. Some of our previous reports on these cases can be found here and here.


In their Complaint, MMAS explains how the defendants used MMAS's medication adherence scale in their research. In connection with this use, MMAS accused Wolverhampton of breach of contract, claiming that Wolverhampton replaced an "Approved Acknowledgment" (giving credit to MMAS and explaining that the scale was used under license) with a "Fraudulent Acknowledgment," effectively undermining the license and resulting in copyright infringement. They also accused MMAR, Donald and Philip Morisky, and the unidentified individuals of committing tortious interference by deliberately instructing Wolverhampton to replace the acknowledgment.

MMAS is asking for actual and statutory damages, injunctive relief, and attorneys' fees, among other forms of relief. We will provide updates as they become available.